Pelvic floor muscle thickness in women with polycystic ovary syndrome

Melo, Marcia; Micussi, Maria Thereza Albuquerque Barbosa Cabral; Medeiros, Robinson Dias de; Cobucci, Ricardo Ney; Maranhão, Técia Maria de Oliveira; Gonçalves, Ana Katherine

doi:10.12891/ceog4113.2018

Cited by 4 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A different claim was reported by Antonio et al, who have shown no difference in the PFMs strength between PCOS women and those of the control group [13]. Another study found no difference in the frequency of reporting urine loss between PCOS and control groups with normal BMI and BMI > 25 [18]. On the contrary, this study showed that the women in the PCOS group had higher scores in the urinary distress inventory-6 domain of the PFDI-20 compared to the non-PCOS group (control) of a matched BMI.…”

Section: Discussionmentioning

confidence: 77%

Prevalence of pelvic floor dysfunction among women with polycystic ovarian syndrome: a case-control study

et al. 2023

View full text Add to dashboard Cite

Background Pelvic floor dysfunction (PFD) is a wide term, involving a large array of conditions that negatively impact many women around the world. Polycystic ovarian syndrome (PCOS) is another disorder with long-term serious consequences. Being a disease of hormonal imbalances, PCOS may possibly affect the function of the pelvic floor muscles leading to PFD. Thus, the current study aimed to explore the prevalence of PFD among women with PCOS. Methods This is an observational, case-control study. A total of 368 women, aged from 20 to 35 years, with a body mass index (BMI) range of 20 to 30 kg/m2 recruited from Kasr El-Ainy teaching hospital shared in the study. They were classified into case group (PCOS patients; n=184) and control group (non-PCOS participants; n=184), with matched age and BMI for comparison. All case-group women were diagnosed with PCOS, based on Rotterdam diagnostic criteria, while the control group women had regular menstrual cycles. Pelvic Floor Distress Inventory-20 (PFDI-20) was used to identify PFD in the tested groups. The demographic features of the two groups were compared using the unpaired t test, while the chi-squared test was used to determine the prevalence of PFD among women with PCOS. Also, multiple linear regression was done to asses other PFD risk factors in both groups. Results Out of 380 women, 368 were involved in the study with mean ± standard deviation (SD) for the age and BMI of 28.48±4.87 years and 25.9±5.8 kg/m2, respectively, for the control group, and 28.76±5.33 years and 27±6.1 kg/m2, respectively, for the PCOS group, without a significant difference in either of the age and BMI between groups (P > 0.05). The frequency distribution of women with and without PFD in both groups revealed that the PCOS group included 68 (37%) women with PFD. While the control group included 12 (6%) women with PFD, with a significant difference (P=0. 03) in the prevalence between both groups. Also, multiple regression revealed that PCOS condition significantly affected PFD. Conclusion PFD was prevalent among women with PCOS, compared to the control group, suggesting a possible link between both conditions.

show abstract

Section: Discussionmentioning

confidence: 77%

Prevalence of pelvic floor dysfunction among women with polycystic ovarian syndrome: a case-control study

et al. 2023

View full text Add to dashboard Cite

show abstract

Pelvic floor parameters in women with gynecological endocrinopathies: a systematic review

Fante¹,

Ferreira

Juliato³

et al. 2020

Rev. Assoc. Med. Bras.

View full text Add to dashboard Cite

SUMMARY There is no pooled information about pelvic floor parameters (muscle assessment, disorders) of women with gynecologicaL endocrinopathies (eg. polycystic ovary syndrome, congenital adrenal hyperplasia, premature ovarian insufficiency). Given that, a systematic review was performed on the Pubmed, Scopus, Google Scholar, Scielo and PEDro databases regarding the main gynecological endocrinopathies [polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI), congenital adrenal hyperplasia (CAH) and hyperprolactinemia (HPL)] since their inception to April 2020. Data quality assessment was made by the Newcastle-Ottawa Scale (NOS) adapted for cross-sectional studies. A total of 4,272 results were retrieved from all databases. After excluding duplicate results and screening by title and abstract, nine studies were selected for quantitative analysis. Seven studies were performed with women with PCOS and two studies with POI. Women with PCOS presented a higher prevalence of urinary incontinence (UI) among obese women, a higher thickness of the levator ani muscle, and higher levels of muscle activity measured by surface electromyograph when compared to the control women. Regarding POI, there was no association with UI, FI, and POP. NOS found that the quality assessment for these selected studies ranged from 5 to 8. We concluded that higher pelvic muscle activity and volume were found in women with PCOS, with further studies needed to confirm this data. Literature was scant about POI, CAH, and HPL.

show abstract

<p>Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review</p>

Naz¹,

Tehrani²,

Behroozi-Lak³

et al. 2020

RRU

View full text Add to dashboard Cite

Pelvic floor dysfunction is one of the most common disorders in women that is associated with social and economic consequences. In general, this disorder imposes direct and indirect costs on the economy of various societies. This review aimed to investigate pelvic floor dysfunction in women with polycystic ovary syndrome (PCOS). In this narrative review, the published articles on pelvic floor dysfunction were examined in PubMed, Scopus, Web of Sciences and Google Scholar. We searched for terms related to polycystic ovary syndrome and pelvic floor dysfunction. Inclusion criteria of this research were observational, experimental, and review studies. In this investigation, the complications associated with polycystic ovary syndrome were examined as risk factors for pelvic floor dysfunction. In this narrative review, we discuss about changes in hormone levels, obesity and overweight, hormonal medications and complications such as diabetes and metabolic disorders and obstetric complications of PCOS can be involved in the pathophysiology of pelvic floor dysfunctions, including stress urinary incontinence and pelvic organ prolapse in women with PCOS. This review highlights knowledge gaps about protective effect of hyperandrogenism on pelvic floor dysfunction as well as destructive effect of metabolic changes on pelvic floor dysfunction in women with PCOS. Further cohort and prospective studies are recommended in women with PCOS to investigate the concept of pelvic organ dysfunction in these women.

show abstract

Pelvic floor muscle thickness in women with polycystic ovary syndrome

Cited by 4 publications

References 20 publications

Prevalence of pelvic floor dysfunction among women with polycystic ovarian syndrome: a case-control study

Prevalence of pelvic floor dysfunction among women with polycystic ovarian syndrome: a case-control study

Pelvic floor parameters in women with gynecological endocrinopathies: a systematic review

<p>Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review</p>

Contact Info

Product

Resources

About